Details for 2012718949
Up to date per 02.04.2026
Actions
Details for 2012718949
Granted/Registered
European Patent
05.03.2014 A
12.07.2017 B1
28.04.2011
SE
1150371
15.09.2011
US
201161535126 P
A61K 38/05 20060101AFI20121115BHEP
Owner
Oncopeptides Innovation ABLuntmakargatan 46111 37 StockholmSE
Representative
Representative
Weiser Voith Gugler Patentanwälte PartnerschaftKopfgasse 71130 WienAT
Inventor
SPIRA, JackNäsbyvägen 38 S-135 53 TyresöSE
LEHMANN, FredrikKanalvägen 61 191 34 SollentunaSE
Information about Fees